Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
李爱国应助Jeffrey2026采纳,获得10
4秒前
一只小鲨鱼完成签到,获得积分20
4秒前
Akim应助旦皋采纳,获得10
4秒前
的li发布了新的文献求助10
4秒前
小饼完成签到 ,获得积分10
5秒前
源源完成签到 ,获得积分10
5秒前
无花果应助香菜碗里来采纳,获得10
8秒前
土块发布了新的文献求助10
9秒前
10秒前
好好好完成签到,获得积分10
12秒前
13秒前
13秒前
浩然发布了新的文献求助10
14秒前
14秒前
丘比特应助番茄酱采纳,获得10
14秒前
shirly发布了新的文献求助10
15秒前
16秒前
limo发布了新的文献求助30
17秒前
xiaozhang完成签到 ,获得积分10
18秒前
木子李发布了新的文献求助10
18秒前
19秒前
20秒前
22秒前
shirly完成签到,获得积分10
22秒前
23秒前
23秒前
郑可馨完成签到 ,获得积分10
23秒前
zero完成签到,获得积分10
23秒前
高脚杯关注了科研通微信公众号
25秒前
25秒前
Fiona完成签到 ,获得积分10
25秒前
26秒前
zhuo完成签到,获得积分10
27秒前
27秒前
尘间雪完成签到,获得积分10
28秒前
李爱国应助大胆的枕头采纳,获得10
28秒前
30秒前
haha发布了新的文献求助10
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Various Faces of Animal Metaphor in English and Polish 800
Signals, Systems, and Signal Processing 610
Photodetectors: From Ultraviolet to Infrared 500
On the Dragon Seas, a sailor's adventures in the far east 500
Yangtze Reminiscences. Some Notes And Recollections Of Service With The China Navigation Company Ltd., 1925-1939 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6353832
求助须知:如何正确求助?哪些是违规求助? 8168974
关于积分的说明 17195165
捐赠科研通 5410113
什么是DOI,文献DOI怎么找? 2863886
邀请新用户注册赠送积分活动 1841322
关于科研通互助平台的介绍 1689961